Mana Capital Acquisition (MAAQ) Short Interest Ratio & Short Volume

Short interest is the volume of Mana Capital Acquisition shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 400 shares of MAAQ short. 0.01% of Mana Capital Acquisition's shares are currently sold short. Learn More on Mana Capital Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Mana Capital Acquisition's floating shares are currently sold short.

Mana Capital Acquisition saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 400 shares, a drop of 71.4% from the previous total of 1,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Mana Capital Acquisition currently has issued a total of 8,125,000 shares. Some of Mana Capital Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mana Capital Acquisition currently has a public float of 6,530,000 shares.

0.01% of Mana Capital Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Mana Capital Acquisition: Leap Therapeutics, Inc. (11.30%), MEI Pharma, Inc. (0.07%), Trinity Biotech plc (0.96%), 23andMe Holding Co. (11.90%), Flora Growth Corp. (2.06%), Marker Therapeutics, Inc. (2.64%), Synlogic, Inc. (0.43%), IN8bio, Inc. (0.74%), ProPhase Labs, Inc. (6.76%), Hoth Therapeutics, Inc. (1.70%),

As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling MAAQ is an investing strategy that aims to generate trading profit from Mana Capital Acquisition as its price is falling. MAAQ shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Mana Capital Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MAAQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MAAQ, twice per month. The most recent reporting period available is July, 31 2022.